Fingerprint
Dive into the research topics of 'CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models
Agnieszka K. Witkiewicz, Derek Cox, Erik S. Knudsen
Research output: Contribution to journal › Article › peer-review
94
Scopus
citations